OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Gastroenterology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Editorial introductions	63
Small varices in chronic liver diseases	53
Hepatitis E virus: has anything changed?	35
Cholangioscopy for biliary diseases	32
Updates and innovations in therapeutic endoscopy	30
Clostridioides difficile infections; new treatments and future perspectives	28
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	28
Editorial introductions	26
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	25
Using nutrition to help recovery from infections	24
Mucosal defense: gastroduodenal injury and repair mechanisms	24
Medical malpractice and gastrointestinal endoscopy	24
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	23
Stomach and duodenum: what's current in 2023	23
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	19
Current and future microbiome-based therapies in inflammatory bowel disease	17
Editorial introductions	17
Carnitine derivatives beyond fatigue: an update	16
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	16
COVID-19 vaccine-induced liver injury	15
Small bowel lymphoma: clinical update and challenges for the gastroenterologist	15
A brave new world: the gastrointestinal lab during and after a pandemic	15
Considerations when starting patients on multiple biologics and small molecules	15
The gut virome in health and disease: new insights and associations	13
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	13

Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come	13
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	13
Interactions between the environmental and human microbiota in the preservation of health and genesis of disease: symposium report	13
Prognostic modeling in biliary diseases	12
Gastroparesis: time for a paradigm change	11
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections	11
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	11
Gastric submucosal mass lesions	11
Clinical and translational markers of severity and prognosis in chronic pancreatitis	11
Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems	11
Implications of Paneth cell dysfunction on gastrointestinal health and disease	11
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	10
Endoluminal bariatric and metabolic therapies: state-of-the-art	10
Advances in endoscopic management of colonic diverticular bleeding	10
Ergonomic wellness for the trainee in gastrointestinal endoscopy	10
Machine and deep learning in inflammatory bowel disease	10
Celiac disease and nonceliac enteropathies	10
Role of albumin in the treatment of decompensated liver cirrhosis	10
Tight junction proteins and biliary diseases	10
Bidirectional relationship between acute pancreatitis and pancreatic cancer	10
Endoscopic management of colonic perforations	10
Intestinal proteases	9
Alterations in microbiome associated with acute pancreatitis	9
Bile acid diarrhea – as bad as it gets?	9
Diagnosis and management of acute lower gastrointestinal bleeding	9
Nutritional aspects in patients with gastroparesis	9
Editorial introductions	9
Artificial intelligence within the small bowel: are we lagging behind?	9
Managing the older adult with inflammatory bowel disease: is age just a number?	9
Histological evaluation in biliary diseases	8
Endoscopic approaches to the management of hemorrhoids	8
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	8
Advances in the evaluation and treatment of autoimmune hepatitis	8
Updates on therapeutic endoscopic ultrasound	8
The rise of antibiotic resistance in Campylobacter	8
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	7
Third space endoscopy: the future of treating gastrointestinal dysmotility	7
The spectrum of diabetes in acute and chronic pancreatitis	7
Pathophysiology updates: gastroduodenal injury and repair mechanisms	7
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	7
The status of endoscopic therapies for gastroesophageal reflux disease	7
Endoscopic approaches to small intestinal strictures	7
Updates in endoscopic management of ampullary and duodenal adenomas	7
Diet and carcinogenesis of gastric cancer	7
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	7
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	7
Should high-fiber diets be recommended for patients with inflammatory bowel disease?	7
Editorial introductions	7
Editorial: Advances in hepatology: 2022	7
Neurological disorders and small bowel dysmotility	6

Editorial introductions	6
Advances in colon-targeted drug technologies	6
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future steps	6
Intestinal transplantation: an update	6
Editorial: The next-generation toolkit for exploring biliary diseases	6
The vermiform cecal appendix, expendable or essential? A narrative review	6
Editorial introductions	6
Bulking agents in gastrointestinal endoscopy: present applications and future advances	6
Editorial introductions	6
The use of artificial intelligence in colonoscopic evaluations	6
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials	5
Small bowel intussusception – aetiology & management	5
Editorial introduction	5
Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis	5
Endoscopic therapy for gastroesophageal reflux disease: where are we, where are we going?	5
A ramble through the small bowel	5
Immune markers of severe acute pancreatitis	5
Endoscopic simulators: training the next generation	5
Retention of small bowel capsule endoscopy	5
The bi-directional role of the gut–brain axis in inflammatory and other gastrointestinal diseases	5
Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities	5
Editorial: Stomach and duodenum: what is current in 2022?	5
How provocative tests in addition to wet swallows during high-resolution manometry can direct clinical management	5
Update on extraesophageal manifestations of gastroesophageal reflux	5
Management of refractory inflammatory bowel disease	5
Role of endoscopy on enteral feeding	5
Small bowel Crohn's disease: optimal modality for diagnosis and monitoring	5
Targeting osteopontin to treat primary sclerosing cholangitis	5
Editorial: Pathology in the small bowel – challenges, trials and tribulations	4
Interpretation of serum pancreatic enzymes in pancreatic and nonpancreatic conditions	4
Small intestinal bacterial overgrowth: current update	4
Mast cell activation and nutritional disorders in patients with hypermobility	4
Bile acids as metabolic regulators: an update	4
Road map to small bowel endoscopy quality indicators	4
Can SARS-CoV-2 be transmitted via faeces?	4
Gastroparesis	4
Editorial: The future of inflammatory bowel disease management	4
Role of gut–kidney axis in renal diseases and IgA nephropathy	4
Macrophages in cholangiopathies	4
The evaluation of liver abnormalities in inflammatory bowel disease patients	4
The role of the microbiome in liver disease	4
Nutritional deficiencies in alcohol use disorder/alcohol-associated liver disease	4
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management	4
Update on pain management in acute pancreatitis	4
Imaging of the biliary tract	4
Population level screening for celiac disease: is now the time?	4
Noninvasive evaluation of fibrosis in adult biliary diseases	3
Editorial introductions	3
Editorial: food, nutrition and the microbiome in health and disease	3
Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract – a systematic review	3
Cellular senescence in the cholangiopathies	3
Colon polyps: updates in classification and management	3
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice	3
Incretin mimetics and acute pancreatitis: enemy or innocent bystander?	3
Editorial introductions	3
Drug-induced bile duct injury: new agents, new mechanisms	3
Integrins in biliary injury and fibrosis	3
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?	3
Selection of endoscopic resection technique for large colorectal lesion treatment	3
Clostridium difficile in inflammatory bowel disease	3
A Practical guide to selecting and using new Crohn's disease therapies	3
Neuro-immune cell interactions in the regulation of intestinal immune homeostasis	3
Precision medicine: how multiomics will shape the future of inflammatory bowel disease?	3
Editorial introductions	3
Endobariatrics: well past infancy and maturing rapidly	3
A practical guide to selecting and using new ulcerative colitis therapies	3
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors	3
Lichen planus esophagitis	3
The role of the fibroblast in Barrett's esophagus and esophageal adenocarcinoma	3